Letter to the Editor: Recurrent Cryoglobulinemic Vasculitis in the Era of Direct-Acting Antivirals: A Story Beyond Sustained Virological Response 12
- PMID: 33884650
- DOI: 10.1002/hep.31860
Letter to the Editor: Recurrent Cryoglobulinemic Vasculitis in the Era of Direct-Acting Antivirals: A Story Beyond Sustained Virological Response 12
Comment in
-
REPLY.Hepatology. 2021 Nov;74(5):2910. doi: 10.1002/hep.31861. Hepatology. 2021. PMID: 33876833 No abstract available.
Comment on
-
Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis.Hepatology. 2021 Sep;74(3):1164-1173. doi: 10.1002/hep.31804. Epub 2021 May 26. Hepatology. 2021. PMID: 33721342 Free PMC article.
References
-
- Gragnani L, Lorini S, Marri S, Basile U, Santarlasci V, Monti M, et al. Haematological and genetic markers in the rational approach to HCV SVR patients with or without persisting cryoglobulinemic vasculitis. Hepatology 2021. https://doi.org/10.1002/hep.31804. [Epub ahead of print]
-
- Heffernan A, Cooke GS, Nayagam S, Thursz M, Hallett TB. Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model. Lancet 2019;393:1319-1329.
-
- Mazzaro C, Maso LD, Visentini M, Ermacora A, Andreone P, Gattei V, et al. Hepatitis C virus-associated indolent B-cell lymphomas: a review on the role of the new direct antiviral agents (DAAs) therapy. Hematol Oncol 2021. https://doi.org/10.1002/hon.2862. [Epub ahead of print]
-
- Mazzaro C, Dal Maso L, Mauro E, Visentini M, Tonizzo M, Gattei V, et al. Hepatitis C virus-related cryoglobulinemic vasculitis: a review of the role of the new direct antiviral agents (DAAs) therapy. Autoimmun Rev 2020;19:102589.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
